Review: The fiber length of Coalinga chrysotile: Enhanced clearance due to its short nature in aqueous solution with a brief critique on "short fiber toxicity"

Indoor and Built Environment

Volumn 17, Issue 1, 2008, Pages 5-26

  Ilgren, E ^a  

^a NONE   (United States)

Author keywords

Clearance; Coalinga chrysotile; Length; Short fiber; Toxicity

Indexed keywords

ASBESTOS; CHRYSOTILE;

AQUEOUS SOLUTION; ARTIFACT; CELL SIZE; CHEMICAL COMPOSITION; FIBER; HEALTH HAZARD; MACROPHAGE; NONHUMAN; POLLUTANT; PRIORITY JOURNAL; REVIEW; TOXICITY TESTING;

ANIMALIA;

EID: 38849111300     PISSN: 1420326X     EISSN: 14230070     Source Type: Journal    
DOI: 10.1177/1420326X07086427     Document Type: Review

References (133)

1. Morgan A.: Acid leaching studies of chrysotile asbestos from mines in the Coalinga region of California and from Quebec and British Columbia: Ann Occup Hyg 1997 ; 41 (3). 249 - 268.
2. Ilgren E., Chatfield E.: Coalinga fibre - a short, amphibole - free chrysotile. Part 1: evidence for lack of fibrogenic activity: Indoor Built Environ 1997 ; 6: 264 - 276.
3. Stanton M., Layard M., Tegeris A., Miller E., May M., Morgan E., Smith A: Relation of particle dimension to carcinogenicity in amphibole asbestos and other fibrous minerals J Natl Cancer Inst 1981 ;67: 965 - 975.
4. Langer A., Wolff M., Rohl A., Selikoff I.: Variation of properties of chrysotile asbestos subjected to milling: J. Tox Environ. Hlth 1978 ; 4: 173 - 188.
5. Davis JMG: The role of clearance and dissolution in determining the durability or biopersistence of mineral fibers: Environ Health Perspect 1994 ; 102 (S5): 113 - 117.
6. Eastern Research Group. Report on the expert panel on health effects of asbestos and synthetic vitreous fibers: the influence of fiber length. Prepared for the agency for toxic substances and disease registry division of Health Assessment and Consultation Atlanta, GA, 2003.
7. Bernstein DM, Hoskins JA: The health effects of chrysotile: Current perspective based upon recent data: Reg Tox Pharm 2006 ; 45: 252 - 264.
8. Browne K.: A threshold for asbestos related lung cancer ; in Sluyser M (ed.): Asbestos Related Cancer. Chichester, UK, Ellis Horwood, 1991, pp. 218 - 40.
9. Berman W., Crump K., Chatfield E., Davis J., Jones A.: The sizes, shapes and mineralogy of asbestos structures that induce lung tumors or mesotheliomas in AF/HAN rats following inhalation: Risk Anal 1995 ; 15: 181 - 195.
10. Berman W., Crump B.: Methodology for conducting risk assessments at asbestos superfund sites. Parts 1 & 2. Methodology & technical background documents. Prepared for Kent Kitchingman, US EPA, Region 9, San Francisco, Under EPA Review, 1999.
11. Davis JM, Jones A.: Comparisons of the pathogenicity of long and short fibres of chrysotile asbestos in rats: Br J Exp Pathol 1988 ; 69: 717 - 737.
12. Langer A., Mackler A., Pooley F.: Electron microscopic investigation of asbestos fibers: Environ Hlth Perspect 1974 ; 9: 63 - 80.
13. Langer A., Rohl A., Wolff M., Selikoff I.: Asbestos, fibrous minerals and acicular cleavage fragments: nomenclature and biological properties ; in Lemen R, Dement JM (eds): Dusts and Disease (occupational and environmental exposures to selected fibrous and particulate dusts). Research Triangle Park, NC, Pathotox Publishers, Inc., 1979, pp. 1 - 22.
14. Zoltai T.: Asbestiform and acicular mineral fragments: Ann NY Acad Sci 1979 ; 330: 621 - 643.
15. NRC - National Research Council: Asbestiform fibers. Non-occupational health risks, National Academy Press, 1984.
16. Hodgson A. Asbestos. UK, Anjelena Press, 1986.
17. Chatfield E.: Testimony ; in Conwed Corp. v Union Carbide Corp. 12 Sept 2002 (available from the author on request).
18. Ilgren E.: Coalinga chrysotile: dissolution, concentration, regulation and general relevance: Indoor Built Environ 2008 ; 17: 42 - 57.
19. Pinkerton K., Brody A., McLaurin D., Adkins B., O'Connor R., Pratt P., Crapo JD: Characterization of three types of chrysotile asbestos after aerosolization: Environ Res 1983 ; 31: 32 - 53.
20. Campbell W., Huggins C., Wylie A.: Chemical and physical characterization of amosite, chrysotile, and nonfibrous tremolite for oral ingestion studies by the National Institutes of Environmental Health Sciences, US Bur Mines Rep Invest #8452, 1980, p. 63.
21. Timbrell V.: Human exposure to asbestos: dust controls and standards. The inhalation of fibrous dusts: Ann NY Acad Sci 1965 ; 133: 255 - 273.
22. Muhle H., Pott F., Bellman B., Takenaka S., Ziem U.: Inhalation and injection experiments in rats to test the carcinogenicity of MMMF: Ann Occup Hyg 1987 ; 131: 755 - 764.
23. Longo W.: Measurement of airborne chrysotile structure sizes from Calidria asbestos. Materials Analytical Services [MAS], Inc. Revision #2, Feb., 2002 (available from the author on request).
24. Longo W.: Testimony ; in Moore v ACandS et al. 19 Sept 2002 (available from the author on request).
25. Longo, W.: Testimony ; in Flowers v Aventis Cropscience USA et al. 5 Nov 2002 (available from the author on request).
26. Yamate G. Agaiwai S, Gibbons R.: Methodology for the measurement of airborne asbestos in electron microscopy, US EPA Report No. 69-02-3266. US EPA, Wash., DC, 1984.
27. Bernstein DM, Chevalier J., Smith P.: Comparison of Calidria chrysotile asbestos to pure tremolite: inhalation biopersistence and histopathology following short-term exposure: Inhal Tox 2003 a; 15: 1387 - 1419.
28. Bernstein DM, Mast R., Anderson T., Hesterberg T., Musselman R., Kamstrup O., Hadley J.: An experimental approach to the evaluation of the biopersistence of respirable synthetic fibers and minerals: Environ Health Perspect 1994 ; 102 (Suppl. 5). 15 - 18.
29. Bernstein DM, Rogers R., Smith P.: The biopersistence of Canadian chrysotile asbestos following inhalation: Inhal Tox 2003 b; 15: 1247 - 1274.
30. Bernstein DM, Rogers R., Smith P.: The biopersistence of Brazilian chrysotile asbestos following inhalation: Inhal Tox 2004 ; 16: 1 - 28.
31. Chatfield E.: Testimony ; in Conwed Corp. v Union Carbide Corp. 27 Oct 2003 (available from the author on request).
32. Rendall REG: The data sheets on the chemical and physical properties of the UICC standard reference samples. Pneumoconiosis. Proc Intl Conf, Johannesburg 1969, Published 1970, pp. 23- 27.
33. Timbrell V.: Characteristics of the International Union against Cancer standard reference samples of asbestos. Pneumoconiosis. Proc. Intl. Conf, Johannesburg 1969, Shapiro HA (ed.), Oxford University Press, Cape Town, 1970, pp. 28-36.
34. Yeager H., Russo D., Yanez M., Gerardi D., Nolan R., Kagan E., Langer A.: Cytotoxicity of a short-fiber chrysotile asbestos for human alveolar macrophages: Preliminary observations: Environ Res 1983 ; 30, 224 - 232.
35. Nolan R., Langer A. Addison J: Lung content analysis of cases occupationally exposed to chrysotile asbestos: Environ Health Perspect 1994 ; 102 (Suppl 5). 245 - 250.
36. Langer A.: Reduction of the biological potential of chrysotile asbestos arising from conditions of service on brake pads: Reg Tox Pharm 2003 ; 38: 71 - 77.
37. Wylie AG: Fibre length and aspect ratio of some selected asbestos samples: Ann NY Acad Sci 1979 ; 330: 605 - 610.
38. Siegrist HG, Wylie AG: Characterizing and discriminating the shape of asbestos particles: Environ Res 1980 ; 23: 348 - 361.
39. Asteco: Fiber size determination and distribution of RG-244 Calidria chrysotile asbestos by TEM [3 Feb. 1993] RG-244 Fiber Size. Job No: 12515 ASTECO Inc.
40. Egilman D., Roberts M.: Controlled use of asbestos: Intl J Occup Environ Hlth 2004 ; 10: 99 - 103.
41. Ilgren E., Chatfield E.: Coalinga fibre - a short, amphibole - free chrysotile. Part 2: evidence for lack of tumorigenic activity: Indoor Built Environ 1998 ; 7: 18 - 31.
42. Ilgren E., Chatfield E.: Coalinga fibre - a short, amphibole - free chrysotile. Part 3: lack of biopersistence: Indoor Built Environ. 1998 ; 7: 98 - 105.
43. Pinkerton K.: Lung reaction to chronic inhalation of three types of chrysotile asbestos during the lifespan of the Fischer 344 rat, PhD Thesis, Duke University, 1982.
44. Ilgren, E.: Testimony ; in Conwed v Union Carbide 13 Aug 98. (available from the author on request).
45. Vorwald AJ, Durkan TM, Pratt PC: Experimental studies of asbestosis: AMA Arch Ind Hyg Occup Med 1951 ; 3: 1 - 43.
46. Elmes P.: Conflicts in evidence on the health effects of mineral fibres ; in Liddell D, Miller K (eds): Mineral Fibres in Health and Disease. Boca Raton, CRC press, 1991, pp. 321 - 337.
47. Langer A.: Testimony ; in Conwed v Union Carbide Corp. 2002 (available from the author on request).
48. Wylie AG: Relationship between the growth habit of asbestos and the dimensions of asbestos fibers. Mining Eng 1988 ; 5: 1036 - 1039.
49. Ilgren E.: Coalinga fibre - a short, amphibole- free chrysotile. Part 6, lack of amphibole asbestos contamination: Indoor Built Environ 2004 ; 13: 325 - 341.
50. Chwastiak S.: Properties of Colloidal chrysotile asbestos from the Coalinga region of California. 19 Dec 1968. Project No. 458-N11, File No. 19 (available from the author on request).
51. Martin C., Phillips V.: The texture of chrysotile asbestos in relationship to mechanical properties: Mat Sci Eng 1977 ; 30: 81 - 87.
52. Atkinson MAL, O"Sullivan M., Zuber S., Dodson RF: evaluation of the size and type of free particulates collected from unused asbestos-containing brake components as related to potential for respirability: Am J Indust Med 2004 ; 46: 545 - 553.
53. Dodson RF, Williams MG, Corn CJ, Brollo A., Bianchi C.: Asbestos content of lung tissue, lymph nodes and pleural plaques from former shipyard workers: Am Rev Respir Dis 1990 ; 142: 843 - 847.
54. Dodson RF, Williams MG, Corn CJ, Brollo A., Bianchi C.: A comparison of asbestos burden in lung parenchyma, lymph nodes, and plaques: Ann NY Acad Sci 1991 ; 643: 53 - 60.
55. Dodson RF, O'Sullivan M., Corn C., McLarty JW, Hammar SP: Analysis of asbestos fiber burden in lung tissue from mesothelioma patients: Ultrastructural Patholog 1997 ; 21: 321 - 336.
56. Dodson RF, Huang J., Bruce JR: Asbestos content in the lymph nodes of non-occupationally exposed individuals: Am J Indust Med 2000 ; 37: 169 - 174.
57. Dodson RF, Atkinson MAL, Levin JL: Asbestos fiber length as related to potential pathogenicity: A critical review: Am J Indust Med 2003 ; 44: 291 - 297.
58. Mancuso T.: Relative risk of mesothelioma among railroad workers: Am J Indust Med 1988 ; 13: 639 - 657.
59. Lemen RA: Asbestos in brakes: exposure and risk of disease: Am J Indust Med 2004 ; 45: 229 - 237.
60. Kohyama N., Suzuki Y.: Analysis of asbestos fibers in lung parenchyma, pleural plaques, and mesothelioma tissues of North American insulation workers: Ann N Y Acad Sci 1991 ; 643: 27 - 52.
61. Case BW, Sebastien P.: Environmental and occupational exposures to chrysotile asbestos: a comparative micro-analytic study: Arch Environ. Hlth 1987 ; 42: 185 - 191.
62. Sebastien P., Janson X., Gaudichet A., Hirsch A., Bignon J.: Asbestos retention in human respiratory tissues: comparative measurements in lung parenchyma and in parietal pleura ; in Wagner JC (ed): Biological Effects of Mineral Fibres (effets biologiques des fibres minérales). Vol. 1, International Agency for Research on Cancer, Lyon, Scientific Publications No. 30, 1980, pp. 237 - 246.
63. Gibbs AR, Stephens M., Griffiths DM, Blight BJ, Pooley FD: Fibre distribution in the lungs and pleura of subjects with asbestos related diffuse pleural fibrosis: Br J Indust Med 1991 ; 48: 762 - 770.
64. Case BW: Pre-meeting comments ; in: Eastern Research Group Report on the Expert Panel on Health Effects of Asbestos and Synthetic Vitreous Fibers: The Influence of Fiber Length. Prepared for the Agency for Toxic Substances and Disease Registry Division of Health Assessment and Consultation Atlanta, GA, 2003.
65. Suzuki Y.: Deposition testimony; in Asbestos Litigation, Cause No. 2004-039648. Harris County, Texas, 10 May'05 (available from the author on request).
66. Suzuki Y., Yuen SR: Asbestos tissue burden study on human malignant mesothelioma: Indust Health 2001 ; 39 (2). 150 - 160.
67. Suzuki Y., Yuen S.: Asbestos fibers contributing to the induction of human malignant mesothelioma Ann. N Y Acad Sci 2002 ; 982: 160 - 176.
68. Suzuki Y., Yuen S.: Erratum to "Short, thin asbestos fibers contribute to the development of human malignant mesothelioma": pathological evidence: Intl J Hyg Environ Hlth 2005 ; 208: 439 - 444.
69. Boutin C., Dumortier P., Rey F., Viallat JR, De Vuyst P.: Black spots concentrate oncogenic asbestos fibers in the parietal pleura. Thoracoscopic and mineralogic study: Am J Respir Crit Care Med 1996 ; 153 (1). 444 - 449.
70. Dumortier P., Rey F., Viallat JR, Broucke I., Boutin C., De Vuyst P.: Chrysotile and tremolite asbestos fibers in the lungs and parietal pleura of Corsican goats: Occup Env Med 2002 ; 59: 643 - 646.
71. Le Bouffant L., Martin JC, Durif S., Daniel H.: Structure and Composition of Pleural Plaques. Biological Effects of Asbestos. IARC - Lyon, France, IARC Scientific Publications No.8, 1973, pp. 249 - 257.
72. Wang NS: The preformed stroma connecting the pleural cavity and the lymphatics in the parietal pleura: Am Rev Respir Dis 1975 ; 111: 12 - 20.
73. Holt P.: Translocation of inhaled dust to the pleura: Environ Res 1983 ; 31: 212 - 220.
74. Beattie J., Knox JF Studies of mineral content and particle size distribution in the lungs of asbestos textile workers; in Davis CN (ed): Inhaled Particles and Vapours, Oxford, Pergamon, 1961, pp. 419 - 432.
75. Hourihane D.: The pathology of mesotheliomata and an analysis of their association with asbestos exposure: Thorax 1964 ; 19, 268 - 278.
76. Hillerdal G.: Pleural Plaques, Doctoral thesis, Uppsala Univ., Sweden, 1980.
77. Holt PF: Dust elimination from pulmonary alveoli: Environ Res 1980 ; 23: 224 - 227.
78. Leak LV, Rahil K.: Permeability of the diaphragmatic mesothelium: the ultrastructure of stomata: Am J Anal 1978 ; 151: 557 - 594.
79. Taskinen E., Ahlamn K., Wukeri M.: A current hypothesis of the lymphatic transport of inspired dust to the parietal pleura: Chest 1973 ; 64: 193 - 202.
80. Selikoff IJ: The occurrence of pleural calcification among asbestos insulation workers: Ann NY Acad Sci 1965 ; 132: 351 - 367.
81. Herbert A.: Pathogenesis of pleurisy, pleural fibrosis and mesothelial proliferation: Thorax 1986 ; 41: 176 - 189.
82. Bignon J., Monchaux G, Hirsch. A, Sebastien P, Lafuma J: Human and experimental data on translocation of asbestos fibers through the respiratory system: Ann N Y Acad Sci 1979 ; 330: 745 - 749.
83. Bignon J., Sebastien P., Gaudichet A., Bonnaud G.: in Gravatt CC, Lafleur PD, Heinrich JFK (eds): Workshop on Asbestos: Definitions and Measurement Methods. Washington DC, NBS Special Publication 506, 1978 ; pp. 95 - 119.
84. Sebastien P., Fondimare A., Bignon J., Monchaux G., Desbordes J., Bonnaud G.: Topographic distribution of asbestos fibres in human lungs in relation to occupational and non-occupational exposure ; in Walton WH, McGovern B (eds): Oxford, Inhaled Particles IV. Pergamon, 1977, pp. 435 - 446.
85. Churg A.: Non-asbestos pulmonary mineral fibers in the general population: Environ Res 1983 ; 31: 189 - 200.
86. Churg A.: The pathogenesis of pleural plaques: Indoor Built Environ 1997 ; 6: 73 - 78.
87. Morgan A., Holmes A.: The distribution and characteristics of asbestos fibers in the lungs of Finnish Anthophyllite mine-workers: Environ Res 1984 ; 33 (1). 62 - 75.
88. Wright GW, Kuschner M.: The influence of varying lengths of glass and asbestos fibres on tissue response in guinea pigs ; in Walton WH, McGovern B (eds): Inhaled Particles IV, Part 2. Oxford, Pergamon, 1977, pp. 455 - 474.
89. Rey F., Viallat JR, Tarisse P., Boutin C.: Pleural migration of asbestos fibres after tracheal injection in rats: Eur Respir Rev 1993 ; 3: 145 - 147.
90. Kanasawa K.: Exchanges through the pleura. Cells and particles ; in Chrétien J, Bignon J, Hirsch A (eds): The pleura in health and disease. New York, Marcel Dekker Inc., 1985, pp. 195 - 231.
91. Pereira AS, Grande NR: Particle clearance from the canine pleural space into thoracic lymph nodes: an experimental study: Lymphology 1992 ; 25: 120 - 130.
92. Takada, K.: Mesothelial damage and growth: experimental mechanisms: Am J Path 1991 ; 132: 12 - 23.
93. Moalli PA, MacDonald JL, Goodglick LA, Kane AB: Acute injury and regeneration of the mesothelium in response to asbestos fibers: Am J Pathol 1987 ; 128: 126 - 445.
94. Mitchev K., Dumortier P., De Vuyst P.: " Black Spots" and hyaline pleural plaques on the parietal pleura of 150 urban necropsy cases: Am J Surg Path 2002 ; 26: 1198 - 1206.
95. Davis J., Beckett S., Bolton R., Donaldson K.: The effects of intermittent high asbestos exposure (peak dose levels) on the lungs of rats: Br J Exp Path 1980 ; 61: 272 - 280.
96. Davis J., Beckett S., Bolton R., Collings P., Middleton A.: Mass and number of fibers in the pathogenesis of asbestos related lung disease in rats: Br J Cancer 1978 ; 37: 667 - 674.
97. Davis J., Addison J., Bolton R., Donaldson K., Jones A.: Inhalation and injection studies in rats using dust samples from chrysotile asbestos prepared by a wet dispersion process: Brit J Exp Path 1986 ; 67: 113 - 129.
98. Pott F., Dolgner R., Spurny K.: Similarities and dissimilarities between asbestos fibres and man-made mineral fibres with regard to their carcinogenicity in man. Proc Intl Symp Prevention of Occupational Cancer, Helsinki 21-24 April, 1981, International Labor Office Geneva, Occupational Safety and Health Series 1982 ; 46: 118-123.
99. Lippman M.: Asbestos exposure indices: Environ Res 1988 ; 46: 86 - 106.
100. Longo W.: Testimony in Langved v Igley Co et al., 2004 (available from the author on request).
101. Berman W., Chatfield E.: Environmental Asbestos Assessment Manual. Superfund Method for the Determination of Asbestos in Ambient Air. Part 1: Measurement Methods Document. Interim Version. EPA / 540/2-90/005b, 1990 a.
102. Berman, W., Chatfield, E.: Environmental Asbestos Assessment Manual. Superfund Method for the Determination of Asbestos in Ambient Air. Part 2: Technical Background Document. Interim Version. EPA/540/2-90/005b, 1990 b.
103. Davis JMG, Beckett ST, Bolton RE, Donaldson K.: The effects of intermittent high asbestos exposure (peak dose levels) on the lungs of rats: Br J Exp Path 1980 ; 61: 272 - 280.
104. Zoltai T.: Site Visit Report as Consultant to Minnesota Dept of Health (6 Jan 75) (available from the author on request).
105. McConnell, EE, Rutter HA, Ulland BM, Moore JA: Chronic effects of dietary exposure to amosite asbestos and tremolite in F344 rats: Environ Hlth Perspect 1983 ; 53: 27 - 44.
106. McConnell EE, Shefner AM, Rust JH, Moore JA: Chronic effects of dietary exposure to amosite and chrysotile asbestos in Syrian golden hamsters: Environ Hlth Perspect 1983 ; 53: 11 - 25.
107. McConnell EE, Wagner JC, Skidmore JW, Moore JA: A comparative study of the fibrogenic and carcinogenic effects of UICC Canadian chrysotile B asbestos and glass microfibre (JM 100) ; in Biological Effects of Man-made Mineral Fibres (Report on a WHO/IARC meeting), Copenhagen, 20-22 April 1982. 1984 Annex 45: pp. 234-242.
108. IITRI Proj. C06570/C06591 - Investigation of feasibility of XRD thin layer methods for quantitative analysis - [C1], 1984.
109. Timbrell V.: Producing a fibre cloud for animal inhalation experiments, Discussion # 2nd Internat. Conf. Bio. Effects Asbestos - Dresden - April 1968.
110. Egilman D.: Testimony ; in Lustgarten v A W Chesterton et al. 26 Mar 2004 (available from the author on request).
111. Donnet J., Cosme P.: New results on the proton attack of macrofibers of chrysotile. 3rd. Intl. Asbetos Conf, Quebec, 1975.
112. Le Bouffant L.: Physics and chemistry of asbestos dust ; in Wagner JC (ed): Biological Effects of Mineral Fibres (Effets biologiques des fibres minérales). Vol. 1, International Agency for Research on Cancer, Lyon, Scientific Publications No.30, 1980, pp. 15 - 33.
113. Sebastien P., Janson X., Bonnaud G., Riba G., Masse R., Bignon J.: Translocation of asbestos fibers through respiratory tract and gastrointestinal tract according to fiber type and size ; in Lemen R, Dement JM (eds): Dusts and Disease (Occupational and Environmental Exposures to Selected Fibrous and Particulate Dusts Pathotox Publishers Inc., 1979, pp. 65 - 77.
114. Vialliat J., Raybaud F., Passarel M., Boutin C.: Pleural migration of chrysotile fibers after intratracheal injection in rats: Arch Environ Health 1986 ; 41: 282 - 286.
115. Final Report (FRAPR) on the Peer Consultation Workshop to Discuss a Proposed Protocol to Assess Asbestos-Related Risk, Prepared for U.S. Environmental Protection Agency, Office of Solid Waste and Emergency Response, Washington, DC 20460: EPA Contract No. 68-C-98-148, Work Assignment 2003-05 Prepared by: Eastern Research Group, Inc. May 30, 2003.
116. Lockey J.: Pre-meeting comments: in Eastern Research Group Report on the Expert Panel on Health Effects of Asbestos and Synthetic Vitreous Fibers: The Influence of Fiber Length. Prepared for the Agency for Toxic Substances and Disease Registry Division of Health Assessment and Consultation Atlanta, GA, 2003.
117. Case BW, Kuhar M., Harrigan M., Dufresne A.: Lung fiber content of American children aged 8-15 years; preliminary findings ; in Dodgson J, Mc Callum, RI (eds): Inhaled Particles VII, Oxford, Elsevier, Ann Occup Hyg 1994 ; 38 (Supp 1). 639 - 645.
118. Morinaga K., Kohyama N., Yokoyama K., Yasui Y., Hara I., Sasaki M., Suzuki, Y., Sera Y.: Asbestos fibre content of lungs with mesotheliomas in Osaka, Japan: A preliminary report ; in Bignon J, Peto J, Saracci R (eds): Non-occupational Exposure to Mineral Fibres. Lyon, IARC Scientific Publications 90, International Agency for Research on Cancer, 1989, pp. 438 - 443.
119. Doll R.: Concluding remarks ; in Bignon J, Peto J, Saracci R (eds): Non-occupational Exposure to Mineral Fibres, Lyon, IARC Scientific Publications 90, International Agency for Research on Cancer, 1989, pp. 438 - 443.
120. Churg A., Wright JL, Depaoli L., Wiggs B.: Mineralogic correlates of fibrosis in chrysotile miners and millers: Am Rev Respir Dis 1989 ; 139 (4). 891 - 896.
121. Churg A., Wright JL, Vedal S.: Fiber burden and patterns of asbestos related diseases in chrysotile miners and millers: Am Rev Resp Dis 1993 ; 148: 25 - 31.
122. Sebastien P., McDonald JC, McDonald AD, Case B., Harley R.: Respiratory cancer in chrysotile textile and mining industries: exposure inferences from lung analysis: Br J Indust Med 1989 ; 46: 180 - 187.
123. Case BW, Sebastien P.: Fibre levels in lung and correlation with air samples ; in Bignon J, Peto J, Saracci R (eds): Non-occupational Exposure to Mineral Fibres. Lyon, IARC, 1989, pp. 207 - 218.
124. Case BW: Health effects of tremolite. Now and in the future: Ann NY Acad Sci 1991 ; 643: 491 - 504.
125. Case BW Biological indicators of chrysotile exposure. Ann Occup Hyg 1994 ; 38 (4). 503 - 18, 410-411.
126. Kane AB, Bofetta P, Saracci R, Wilbourn JD (eds). Mechanisms of Fibre Carcinogenesis. IARC Sci Pub No 140, Lyon, International Agency for Research on Cancer, 1996.
127. Suzuki Y., Kohyama N.: Translocation of inhaled asbestos fibers from the lung to other tissues: Am J Indust Med 1991 ; 19 (6). 701 - 4.
128. Hiroshima K., Murai Y., Suzuki Y., Goldstein B., Webster I.: Characterization of asbestos fibers in lungs and mesotheliomatous tissues of baboons following long term inhalation: Amer J Indust Med 1993 ; 23: 883 - 901.
129. Rogers AL, Leigh J., Berry G., Ferguson DA, Mulder HB, Ackad M., Morgan GG: Dose-response relationship between airborne and lung asbestos fibre type, length, and concentration, and the relative risk of mesothelioma, Ann Occup Hyg 1994 ; 38 (S1): 631 - 638.
130. Nagelschmidt G.: Some observations of the dust content and composition in lungs with asbestosis made during work on coal miners pneumoconiosis: Ann NY Acad Sci 1965 ; 132: 64 - 76.
131. Thomson JG: Asbestos and the urban dweller: Ann. NY Acad Sci 1965 ; 132: 196 - 214.
132. Brown J.: Atlas of Video Assisted Thoracic Surgery. Oxford, UK, WB Saunders, 1977, Chapter 18, pp. 171 - 183.
133. Ilgren E., Browne K.: Asbestos-related mesothelioma: Evidence for a threshold in humans and animals: Reg Tox Pharm 1991 ; 13: 116 - 132.